Mumbai (Maharashtra) [India], Aug 21 (ANI): India Ratings and Research (Ind-Ra) has said the decline in US sales of Indian companies was attributed to a high single-digit price erosion in US generic market coupled with a continued weak demand for the acute portfolio of products during 1Q FY2
Mumbai (Maharashtra) [India], July 7 (ANI): Indian pharmaceutical companies have built a strong abbreviated new drug application (ANDA) pipeline since FY12 through scaling-up of investments in R&D but this will increase the inspection intensity, India Ratings and Research (Ind-Ra) said o